# Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes

**Authors:** Jiyue Wu, Feilong Zhang, Xiang Zheng, Jiandong Zhang, Peng Cao, Zejia Sun, Wei Wang

PMC · DOI: 10.3389/fimmu.2022.1047367 · Frontiers in Immunology · 2022-12-01

## TL;DR

This study identifies two types of kidney transplant injury based on neutrophil DNA structures and creates tools to predict complications and improve outcomes.

## Contribution

The study introduces a novel classification of renal ischemia reperfusion injury subtypes and predictive models for graft outcomes using NET-related gene expression.

## Key findings

- Two IRI clusters (C1 and C2) with distinct molecular and clinical features were identified.
- DGF and graft survival prediction strategies were developed based on hub NRGs.
- Cxcl1 inhibition improved kidney function and reduced inflammation and NET formation in a mouse model.

## Abstract

Ischemia reperfusion injury (IRI) is an inevitable process in renal transplantation, which is closely related to serious postoperative complications such as delayed graft function (DGF), acute rejection and graft failure. Neutrophil extracellular traps (NETs) are extracellular DNA structures decorated with various protein substances released by neutrophils under strong signal stimulation. Recently, NETs have been found to play an important role in the process of IRI. This study aimed to comprehensively analyze the expression landscape of NET-related genes (NRGs) during IRI, identify clusters with different degrees of IRI and construct robust DGF and long-term graft survival predictive strategies.

The microarray and RNA-seq datasets were obtained from the GEO database. Differentially expressed NRGs (DE-NRGs) were identified by the differential expression analysis, and the NMF algorithm was used to conduct a cluster analysis of IRI samples. Machine learning algorithms were performed to screen DGF-related hub NRGs, and DGF and long-term graft survival predictive strategies were constructed based on these hub NRGs. Finally, we verified the expression of Cxcl1 and its effect on IRI and NETs generation in the mouse IRI model.

This study revealed two IRI clusters (C1 and C2 clusters) with different molecular features and clinical characteristics. Cluster C1 was characterized by active metabolism, mild inflammation and lower incidence of DGF, while Cluster C2 was inflammation activated subtype with a higher incidence of DGF. Besides, based on DGF-related hub NRGs, we successfully constructed robust DGF and long-term graft survival predictive strategies. The mouse renal IRI model verified that Cxcl1 was significantly upregulated in renal tissues after IRI, and using a CXCL8/CXCL1 inhibitor could significantly improve renal function, alleviate renal tubular necrosis, tissue inflammatory response, and NET formation.

This study identified two distinct IRI clusters based on DE-NRGs and constructed robust prediction methods for DGF and graft survival, which can provide references for early prevention and individualized treatment of various postoperative complications after renal transplantation.

## Linked entities

- **Genes:** CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, MPO (myeloperoxidase) [NCBI Gene 4353], Elane (elastase, neutrophil expressed) [NCBI Gene 50701] {aka Ela2, F430011M15Rik, NE}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051] {aka C/EBP-beta, IL6DBP, NF-IL6, TCF5}, Mpo (myeloperoxidase) [NCBI Gene 17523] {aka mKIAA4033}, CXCR1 (C-X-C motif chemokine receptor 1) [NCBI Gene 3577] {aka C-C, C-C-CKR-1, CD128, CD181, CDw128a, CKR-1}, Padis4 (MMTV LTR integration site 4) [NCBI Gene 110072] {aka Pad4}, Ifnab (interferon alpha B) [NCBI Gene 15974] {aka If1ai8}, PADI4 (peptidyl arginine deiminase 4) [NCBI Gene 23569] {aka PAD, PAD4, PADI5, PDI4, PDI5}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, DNAJB1 (DnaJ heat shock protein family (Hsp40) member B1) [NCBI Gene 3337] {aka HSPF1, Hdj1, Hsp40, RSPH16B, Sis1}, MIR4512 (microRNA 4512) [NCBI Gene 100616149], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, P2rx1 (purinergic receptor P2X, ligand-gated ion channel, 1) [NCBI Gene 18436] {aka P2x, Pdcd3, RP-2}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, CXCR2 (C-X-C motif chemokine receptor 2) [NCBI Gene 3579] {aka CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, SGK1 (serum/glucocorticoid regulated kinase 1) [NCBI Gene 6446] {aka SGK}, NFIL3 (nuclear factor, interleukin 3 regulated) [NCBI Gene 4783] {aka E4BP4, IL3BP1, NF-IL3A, NFIL3A}, Kras (Kras proto-oncogene, GTPase) [NCBI Gene 16653] {aka K-Ras, K-Ras 2, K-ras, Ki-ras, Kras-2, Kras2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 20310] {aka CINC-2a, GROb, Gro2, MIP-2, MIP-2a, Mgsa-b}, Cxcl1 (C-X-C motif chemokine ligand 1) [NCBI Gene 14825] {aka Fsp, Gro1, KC, Mgsa, N51, Scyb1}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, Ddit4 (DNA-damage-inducible transcript 4) [NCBI Gene 74747] {aka 5830413E08Rik, REDD1, Rtp801, dig2}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}
- **Diseases:** diabetic (MESH:D003920), COPD (MESH:D029424), renal tubular (MESH:D000141), end-stage renal disease (MESH:D007676), tubular cell death (MESH:D003643), acute kidney injury (MESH:D058186), renal IRI (MESH:D006030), ischemia (MESH:D007511), systemic lupus erythematosus (MESH:D008180), gouty arthritis (MESH:D015210), cancer (MESH:D009369), COVID-19 (MESH:D000086382), necrosis (MESH:D009336), dehydration (MESH:D003681), type 1 diabetes (MESH:D003922), malignant pleural effusions (MESH:D016066), kidney injury (MESH:D007674), NETs (MESH:C536657), dysfunction (MESH:D006331), macrophage (MESH:D055501), liver injury (MESH:D017093), renal tubular necrosis (MESH:D007683), thrombosis (MESH:D013927), AR (MESH:D013734), I/R (MESH:C580424), autoimmune diseases (MESH:D001327), gout (MESH:D006073), IRI (MESH:D015427), infectious diseases (MESH:D003141), Delayed graft function (MESH:D051799), inflammation (MESH:D007249), postoperative complications (MESH:D011183), BD (MESH:D001528), ulcerative colitis (MESH:D003093), inflammatory tissue injury (MESH:D017695), atherosclerotic cardiovascular diseases (MESH:D050197)
- **Chemicals:** fatty acid (MESH:D005227), alcohol (MESH:D000438), Cl- (MESH:D002713), formalin (MESH:D005557), NRGs (-), TRIzol (MESH:C411644), hydrogen peroxide (MESH:D006861), pentobarbital (MESH:D010424), urea (MESH:D014508), H&amp;E (MESH:D006371), citrate (MESH:D019343), creatinine (MESH:D003404), heme (MESH:D006418), eosin (MESH:D004801), Paraffin (MESH:D010232), methotrexate (MESH:D008727), hematoxylin (MESH:D006416), ethanol (MESH:D000431), reactive oxygen species (MESH:D017382), bile acid (MESH:D001647), monosodium urate (MESH:D014527), xylene (MESH:D014992)
- **Species:** Homo sapiens (human, species) [taxon 9606], Haemophilus influenzae (species) [taxon 727], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** AUC at 1, G31P
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), C57BL/6 N — Mus musculus (Mouse), Embryonic stem cell (CVCL_2H81)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC9752097/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC9752097/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC9752097/full.md

---
Source: https://tomesphere.com/paper/PMC9752097